Author:
Khurana Surender,Coyle Elizabeth M.,Manischewitz Jody,King Lisa R.,Ishioka Glenn,Alexander Jeff,Smith Jon,Gurwith Marc,Golding Hana
Publisher
Public Library of Science (PLoS)
Reference32 articles.
1. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials;JE Ledgerwood;The Lancet infectious diseases,2011
2. Talaat KR, Luke CJ, Khurana S, Manischewitz J, King LR, et al. A live attenuated H5N1 vaccine induces long-term immunity in the absence of a primary antibody response. J Infect Dis. 2014.
3. Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study;M Gurwith;The Lancet infectious diseases,2013
4. MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines;S Khurana;Sci Transl Med,2011
5. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays;T Rowe;J Clin Microbiol,1999
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献